- Home
- PCVX vs KD Comparison
PCVX vs KD Comparison
Compare PCVX & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | KD |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | KD |
|---|---|---|
| Price | $45.72 | $27.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $105.00 | $39.60 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 02-24-2026 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | ★ $15,008,000,000.00 |
| Revenue This Year | N/A | $6.40 |
| Revenue Next Year | N/A | $3.60 |
| P/E Ratio | ★ N/A | $16.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.66 | $23.28 |
| 52 Week High | $93.77 | $44.20 |
Technical Indicators
Market Signals| Indicator | PCVX | KD |
|---|---|---|
| Relative Strength Index (RSI) | 49.67 | 58.31 |
| Support Level | $44.23 | $26.68 |
| Resistance Level | $47.72 | $27.74 |
| Average True Range (ATR) | 1.83 | 0.70 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 37.74 | 87.65 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.